Trial Profile
A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol Following Topical Periocular Administration in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2015
Price :
$35
*
At a glance
- Drugs DCN 01 (Primary)
- Indications Bacterial infections; Ophthalmic infections
- Focus Therapeutic Use
- 31 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 21 May 2013 New trial record